Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03961022
Other study ID # Nat.Origins-ReWin(d)-2019
Secondary ID
Status Completed
Phase Phase 2
First received
Last updated
Start date October 22, 2018
Est. completion date December 21, 2018

Study information

Verified date May 2019
Source Natural Origins
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study will assess the recovery and performance of young athletes suffering from muscle damage induced by physical exercise. Model by comparing the safety and efficacy of ReWin(d) supplemention during 4 weeks to placebo over 72 hours post exercice.


Description:

Double-blind, randomized, placebo controlled, parallel group, pilot safety and efficacy study.

40 healthy young male athetes were randomly assigned to the ReWin(d) or Placebo group. After 4 weeks supplementation (either 2 g daily of ReWin(d) capsules or placebo capsules). the participants were subjected to a 1 hour plyometric exercise session to induce DOMS. At 0 hours, 24 hours, 48 hours and 72 hours post exercise, the volunteers have been assessed to determine: (i) pain perception, (ii) fatigue rate, (iii) sport performance (effectiveness of a jump) and (iv) muscle damage and inflammation by I-R thermography and biomarkers


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date December 21, 2018
Est. primary completion date December 21, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 20 Years to 30 Years
Eligibility Inclusion Criteria:

- > 18 years old

- Young athletes

- Training at least 3 times per week

- Agree not to initiate any new exercise or diet programs during the entire study period

- Agree not to change their current diet or exercise program during the entire study period

- Agree not to stretch, utilize ice massage, take anti-inflammatory medications (eg, aspirin, ibuprofen), or use any other treatment for the duration of the trial.

Exclusion Criteria:

- Previous history of upper extremity injury or knee joint pain

- Use of anti-inflammatory medications or pain medications 1 week before the screening visit and during the study

- Daily use of dietary supplements and herbal supplements beginning at the screening visit and during the study

- Antibiotic use in past 3 months

- Chronic disease

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Polyherbal supplement: ReWin(d) vs Placebo
Supplementation during 4 weeks + 72 hours post acute exercice

Locations

Country Name City State
Spain European University of Madrid Villaviciosa De Odón Madrid

Sponsors (2)

Lead Sponsor Collaborator
Natural Origins European University of Madrid

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Effects of ReWin(d) on muscle recovery induced by physical exercise Sport performance (effectiveness of a jump) after exercise-induced muscle damage Change from baseline at 0 hours, 24 hours, 48 hours and 72 hours post plyometric exercises session to induce DOMS
Secondary Effects of ReWin(d) on muscle damage induced by physical exercise Muscle skin temperature monitored by IR-camera. Change from baseline at 0 hours, 24 hours, 48 hours and 72 hours post plyometric exercises session to induce DOMS
Secondary Effects of ReWin(d) on pain perception induced by physical exercise Visual Analogue Scale pain perception after exercise-induced muscle damage Change from baseline at 0 hours, 24 hours, 48 hours and 72 hours post plyometric exercises session
Secondary Effects of ReWin(d) on fatigue rate induced by physical exercise Heart Rate Variability assessment after exercise-induced muscle damage Change from baseline at 0 hours, 24 hours, 48 hours and 72 hours post plyometric exercises session
Secondary Effects of ReWin(d) on Gut Microbiota Determination of Microbiota composition by 16S rRNA Sequencing. Change from baseline dose after 4 weeks of intervention
See also
  Status Clinical Trial Phase
Completed NCT04371237 - Accelerating Post-exercise Muscle Glycogen Resynthesis in Humans: Impact of Combined Nutrient Intake and Intermittent Pneumatic Compression or Heat Therapy N/A
Completed NCT04182295 - Does Placebo Information Affect the Trial Outcomes and Participant Blinding? N/A
Completed NCT06112899 - The Effects of Swedish Massage and Manual Lymph Drainage on Muscle Fatigue N/A
Completed NCT02923102 - Effects of Recoverben® on Recovery After Exhaustive Exercise N/A
Completed NCT02945098 - Kinesio Taping in Muscle Damage Response Induced by Eccentric Exercise N/A
Completed NCT02271854 - A Within-subject Study to Evaluate the Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Compared to Placebo in Subjects Experiencing Delayed Onset Muscle Soreness Phase 3
Completed NCT01825616 - Vitamin D2, Muscle Damage, NASCAR Pitcrew N/A
Completed NCT00745771 - Multiple Dose, Double-Blind, Placebo and Active Controlled Study of Pharmacokinetics of Diractin® as Well as Safety and Efficacy for the Treatment of Muscle Soreness Phase 2
Completed NCT05037942 - The Effects of Restriction Pressure on Muscle Damage Responses to Blood Flow Restriction Exercise N/A
Completed NCT05276986 - Effects of Delayed Muscle Pain on Respiratory Muscle Function N/A
Completed NCT05100459 - The Effects of Whey Protein Supplements on Markers of Exercise-induced Muscle Damage in Resistance-trained Individuals N/A
Not yet recruiting NCT05607212 - Lumbosacral Muscle Sensitivity & Pressure Pain Threshold After Kettlebell Swings N/A
Completed NCT04742244 - Lemon Verbena Extract Oxidative Stress and Muscle Damage N/A
Not yet recruiting NCT04872374 - Effects of Parmigiano Reggiano on Skeletal Muscle Damage in Older Adults N/A
Completed NCT05998603 - Pre-sleep Protein Supplementation and Load Carriage Recovery in British Army Recruits N/A
Completed NCT04677985 - Analgesic Induces Similar Upper and Lower Body Pain Pressure Threshold Increases N/A
Recruiting NCT03540602 - Polyphenol Rich Supplementation on Markers of Recovery From Intense Resistance Exercise Phase 1
Completed NCT05924139 - Omega-3 Fatty Acid Supplementation to Enhance Performance N/A
Completed NCT04420377 - The Chronic Effects of Carnitine on Recovery N/A
Recruiting NCT05907850 - Effects of Riboflavin in Mitigating Muscle Soreness in Ultra-marathon Athletes Early Phase 1